Overview

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A study conducted on healthy volunteers to determine the safety, tolerability and affect on the human body by experimental drug GSK557296.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Diketopiperazines